FIELD: medicine.
SUBSTANCE: invention discloses use of recombinant human growth hormone (hGH) GX-H9 for treating growth hormone deficiency and a method of treating growth hormone deficiency, comprising administering hGH GX-H9 to a patient with growth hormone deficiency once a week or twice a month in a dose of at least 0.1 mg per kg of body weight of the patient.
EFFECT: presented group of inventions provides effective treatment of growth hormone deficiency.
10 cl, 10 dwg, 12 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR GROWTH HORMONE DEFICIENCY THERAPY COMPRISING FUSED hGH PROTEIN | 2017 |
|
RU2748402C2 |
| LONG-ACTING POLYPEPTIDES AND METHODS OF THEIR PRODUCTION AND ADMINISTRATION | 2014 |
|
RU2798845C2 |
| LONG-ACTING POLYPEPTIDES AND METHODS OF THEIR PREPARATION AND ADMINISTRATION | 2014 |
|
RU2746943C2 |
| METHOD FOR INCREASING NUMBER OF LYMPHOCYTES IN TUMOURS USING HYBRID PROTEIN IL-7 | 2020 |
|
RU2822396C1 |
| METHODS OF TREATING TISSUE CALCIFICATION | 2015 |
|
RU2770698C2 |
| NEW VERSION OF ALPHA-1-ANTITRYPSIN, METHOD OF ITS PRODUCTION AND APPLICATION | 2012 |
|
RU2567007C1 |
| GROWTH HORMONE RECEPTOR BLOCKERS FOR DISEASE PREVENTION AND TREATMENT | 2016 |
|
RU2726254C2 |
| METHODS FOR PRODUCING CTP-MODIFIED POLYPEPTIDES OF A LONG-ACTING GROWTH HORMONE | 2015 |
|
RU2743295C2 |
| TREATMENT OF MUSCULAR WEAKNESS WITH ALKALINE PHOSPHATASES | 2017 |
|
RU2754558C2 |
| ANTI-PD-1 ANTIBODIES | 2017 |
|
RU2752832C2 |
